Medicare Enrolled

Dr. Sidney Goldfarb, MD

Q: Does Dr. Goldfarb receive payments from pharmaceutical companies?

Yes. Dr. Goldfarb received a total of $1,691 from 13 companies across 78 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently High for Dr. Goldfarb) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Urology Physician · Princeton, NJ

419 N HARRISON ST, Princeton, NJ 08540

6099213008

Registered in NPPES since 2006

NPI: 1093776916 verify on NPPES ↗

High

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Goldfarb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Goldfarb? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Goldfarb

Dr. Sidney Goldfarb is an urology physician in Princeton, NJ, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Goldfarb received a total of $1,691 from 13 pharmaceutical and/or device companies across 78 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Goldfarb is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $1,691 industry payments

Industry Payment Transparency

Open Payments through 2023 ↗

$1,691

Total received (2018-2023)

Avg $338/year across 5 years

Bottom 43% in NJ for urology physician

Companies

Payment records

Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023

$79

2021

$583

2020

$200

2019

$407

2018

$423

Payments by company (2023)

Astellas Pharma US Inc

$79

Top 3 companies account for 100.0% of 2023 payments

All-time payments by company (2018-2023) ›

Astellas Pharma US Inc

$827

AbbVie Inc.

$220

PFIZER INC.

$153

Allergan Inc.

$125

UROVANT SCIENCES INC

$119

AbbVie, Inc.

$86

Avadel Specialty Pharmaceuticals, LLC

$40

Ferring Pharmaceuticals Inc.

$29

Janssen Biotech, Inc.

$28

SI-BONE, INC.

$23

DENTSPLY IH Inc.

$14

Myovant Sciences Inc.

$13

TOLMAR Pharmaceuticals, Inc.

$13

Top 3 companies account for 71.0% of all-time payments

Associated products mentioned in payments ›

Androgel · BOTOX · CEREC · ELIGARD · Erleada · FIRMAGON · GEMTESA · IFUSE IMPLANT · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · NOCDURNA · Noctiva · ORGOVYX · TOVIAZ · VESICARE · XTANDI

Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Looking for an urology physician in Princeton?
Compare urology physicians in the Princeton area by procedure volume, costs, and industry payment transparency.

Browse urology physicians nearby

Geographic Context

Urology physicians in nearby ZIP areas

107

County median income

$96,333

Nearest hospital to ZIP centroid (approximate)

UNIVERSITY MEDICAL CENTER OF PRINCETON AT PLAINSBORO
4.3 mi

Data Sources

Provider Registry	✓ NPPES	NPPES snapshot; verify current record
Medicare Enrollment	✓ PECOS	PECOS snapshot
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2023
Disciplinary History	— Not included	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Goldfarb is an urology physician, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Goldfarb receive payments from pharmaceutical companies?

Yes. Dr. Goldfarb received a total of $1,691 from 13 companies across 78 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently High for Dr. Goldfarb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city

Urology Physicians in Princeton

Browse urology physicians in Princeton ranked by procedure volume and transparency data.

Highest volume

Top Urology Physicians in NJ

Urology physicians ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Urology Physicians in NJ

Which NJ urology physicians receive the most from drug and device companies.

By company

Astellas Pharma US Inc Payments to Doctors

See all physicians who received payments from Astellas Pharma US Inc.

By company

AbbVie Inc. Payments to Doctors

See all physicians who received payments from AbbVie Inc.

By company

PFIZER INC. Payments to Doctors

See all physicians who received payments from PFIZER INC.

About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology